Sodium alginate and Oedema peripheral - a phase IV clinical study of FDA data

Summary:

Oedema peripheral is reported as a side effect among people who take Sodium alginate (algin), especially for people who are female, 60+ old, also take Augmentin, and have High blood pressure.

The phase IV clinical study analyzes which people have Oedema peripheral when taking Sodium alginate. It is created by eHealthMe based on reports of 1,324 people who have side effects when taking Sodium alginate from the FDA, and is updated regularly.

What is Sodium alginate?

Sodium alginate has active ingredients of algin. eHealthMe is studying from 1,325 Sodium alginate users. Check the latest studies of Sodium alginate.

What is Oedema peripheral?

Oedema peripheral (superficial swelling) is found to be associated with 2,774 drugs and 3,465 conditions by eHealthMe. Check the latest studies of Oedema peripheral.

On Aug, 10, 2026

1,324 people reported to have side effects when taking Sodium alginate.
Among them, 41 people (3.1%) have Oedema peripheral.

Could Sodium alginate cause Oedema peripheral?

Among these 41 people:

What is the gender of people who have Oedema peripheral when taking Sodium alginate? *

female: 56.41 %
male: 43.59 %

What is the age of people who have Oedema peripheral when taking Sodium alginate? *

What are other drugs people take besides Sodium alginate? *

What are other side effects people have besides Oedema peripheral? *

Acute Kidney Failure: 17 people, 41.46%
Diarrhea: 17 people, 41.46%
Nausea (feeling of having an urge to vomit): 15 people, 36.59%
Fatigue (feeling of tiredness): 15 people, 36.59%
Hypotension (abnormally low blood pressure): 12 people, 29.27%
Rashes (redness): 12 people, 29.27%
Thrombocytopenia (decrease of platelets in blood): 10 people, 24.39%
Hypoglycemia (low blood sugar): 10 people, 24.39%
Hepatocellular Injury (liver injury): 10 people, 24.39%
Hepatic Failure (liver failure): 10 people, 24.39%

What are the existing conditions these people have? *

High Blood Pressure: 11 people, 26.83%
Type 2 Diabetes: 10 people, 24.39%
Bronchopulmonary Aspergillosis (lung disorder caused by aspergillus fungi): 10 people, 24.39%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 10 people, 24.39%
Pain: 8 people, 19.51%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 8 people, 19.51%
Insomnia (sleeplessness): 7 people, 17.07%
Arrhythmias (irregular heartbeat): 7 people, 17.07%
Calcium Deficiency (lack of calcium): 7 people, 17.07%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 7 people, 17.07%

* Approximation only. Some reports may have incomplete information.

Do you take Sodium alginate and have Oedema peripheral?

- Check whether Oedema peripheral is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Sodium alginate:

Sodium alginate (1,325 reports)

Oedema peripheral treatments and more:

Oedema peripheral (172,690 reports)

Browse all side effects of Sodium alginate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Oedema peripheral:

Oedema peripheral (2,774 drugs)

Browse all the conditions that are associated with Oedema peripheral:

Oedema peripheral (3,465 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on algin (the active ingredients of Sodium alginate) and Sodium alginate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.